Caitong International Asset Management’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.7K Buy
+41,320
New +$60.1K 0.01% 699
2026
Q1
– Sell
-69,756
Closed -$96.3K – 3022
2025
Q4
$96.3K Buy
69,756
+67,235
+2,667% +$141K 0.02% 444
2025
Q3
$6.88K Sell
2,521
-325
-11% -$1.16K ﹤0.01% 1133
2025
Q2
$9.93K Buy
2,846
+521
+22% +$2.06K 0.01% 731
2025
Q1
$8.56K Buy
+2,325
New +$8.49K 0.01% 892

Other funds holding STIM

Caitong International Asset Management's STIM Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Neuronetics (STIM) in Q2 2026: 41,320 shares worth $53.7K. The stake represents 0.01% of the portfolio and ranks #699 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in STIM as recently as Q4 2025.

Caitong International Asset Management first reported a position in STIM in Q1 2025 and has held it in 5 quarters since. The position peaked at $96.3K in Q4 2025. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Caitong International Asset Management held 41,320 shares of Neuronetics worth $53.7K as of Q2 2026.
  • Neuronetics was a new Caitong International Asset Management position in Q2 2026.
  • Neuronetics made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #699 holding.
  • Caitong International Asset Management first reported a position in Neuronetics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Neuronetics position peaked at $96.3K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.